Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Respiration Disorders × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 46 Neoplasms 36 Colorectal Neoplasms 23 Lung Neoplasms 22 Prostatic Neoplasms 15 Uterine Cervical Neoplasms 13 Motor Activity 12 Colonic Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Melanoma 8 Lymphoma 8 Anxiety Disorders 8 Urinary Bladder Neoplasms 7 Obesity 7 Hematologic Neoplasms 7 Depression 7 Vulvar Neoplasms 6 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Breast Carcinoma In Situ 6 Sarcoma 5 Pain 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Stomach Neoplasms 4 Papillomavirus Infections 4 Leukemia, Myeloid, Acute 4 Hematopoietic and Lymphoid System Neoplasm 4

Interventions

Surveys and Questionnaires 1 Propofol 1 Midazolam 1 Methods 1 Fluorodeoxyglucose F18 1 Fentanyl 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03750110 2022-05-19

YESS

University of Nottingham

Phase NA Completed

Heart Diseases, Lung Neoplasms, Respiration Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡